Investigation on the Management for Patients with Echinococcosis Treated with Albendazole - Three PLADs, China, 2019

2019年中国三家PLADs医院使用阿苯达唑治疗棘球蚴病患者管理情况调查

阅读:1

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC? In China, patients with echinococcosis receive complimentary healthcare services, such as medical treatment, diagnostic examinations, and follow-up care. Despite this, no studies have been conducted to assess the quality of patient management to date. WHAT IS ADDED BY THIS REPORT? This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties. Out of 634 evaluable patient files, the proportion of patients with a ratio of actual follow-up and reexamination times to theoretical follow-up and reexamination times ≥0.8 were both low (21.92% and 23.19%, respectively). WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICES? This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation, follow-up, and reexamination.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。